Home biotech
 

Keywords :   


Tag: biotech

Norwegian Biotech Flags Evidence for Efficacy of 'Kick and Kill' HIV Treatment

2015-12-22 02:32:12| Biotech - Topix.net

Scanning electron micrograph of HIV-1 budding from cultured lymphocyte. On Monday, Norwegian biotechnology company Bionor Pharma said it had evidence of real promise for an approach to treating HIV that seeks to expose latent HIV-infected cells so they can be cleared away by the immune system.

Tags: treatment evidence kill kick

 

[Newsmaker] With biotech, Samsung heir aims to emulate father's chip success

2015-12-21 14:11:36| Biotech - Topix.net

Samsung Electronics vice chairman and heir apparent Lee Jae-yong is betting big on biotechnology, a move reminiscent of his father, chairman Lee Kun-hee's entry into the chip business almost 40 years ago. In the 1970s, there was widespread skepticism about Samsung's entry in the chip market that was dominated by U.S. and Japanese companies.

Tags: success samsung chip aims

 
 

Ksa Capital Management Purchases Shares of 55,000 SPDR S&P Biotech

2015-12-20 01:38:05| Biotech - Topix.net

KSA Capital Management purchased a new position in SPDR S&P Biotech during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The hedge fund purchased 55,000 shares of the company's stock, valued at approximately $3,423,000.

Tags: management capital shares purchases

 

Biotech: Paul Yook Talks The Long And Short Of It

2015-12-18 04:40:30| Biotech - Topix.net

Paul Yook, co-founder of LifeSci Index Partners and founder and portfolio manager of BioShares, spoke with Benzinga about the biotechnology sector. Paul Yook: In eight of the 10 past years , biotech outperformed the broader market when comparing the Nasdaq Biotechnology Index versus the S&P 500 Index.

Tags: it long short paul

 

Premarket Biotech Digest: Tracking Gilead HCV Sales, Shire-Baxalta Deal, AstraZeneca Deal

2015-12-17 17:08:44| Biotech - Topix.net

The current consensus forecast for fourth quarter HCV sales is $2.81 billion. In the third quarter, U.S. HCV sales had totaled $3.23 billion.

Tags: sales deal tracking digest

 

Sites : [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] next »